Health economics


Since 1 January 2020, the Danish Medicines Council has taken over from Amgros the task of assessing healthcare economic analyses. For more information, visit the Danish Medicines Council website.

THE DANISH MEDICINES COUNCIL AND AMGROS

If a supplier wants to have a new pharmaceutical recommended as a possible standard treatment at Danish public hospitals, the Danish Medicines Council has to assess it first. On the basis of an application from the supplier, the Medicines Council assesses the clinical added value from treatment with the new pharmaceutical and the costs associated with the new treatment.

Since 1 January 2020, the Danish Medicines Council has taken over from Amgros the task of assessing healthcare economic analyses. For more information, visit the Danish Medicines Council website.

The health economic analyses and the added clinical value of the medicine form the basis for price negotiations between the supplier and Amgros.


Health economic analyses taken over by the Danish Medicines Council

Since 1 January 2020, the Danish Medicines Council Secretariat has taken over the task of assessing health economic analyses in connection with recommendations by the Danish Medicines Council of new medicines and indicators.

This means that, in future, questions regarding the healtch economic part of applications for new medicines and indicators should be referred to the Danish Medicines Council Secretariat.

When the Danish Medicines Council has assessed the added clinical value, Amgros still negotiates the price of the medicine

Click here to read the article

Read more

Health economics

Negotiation of prices

When the Danish Medicines Council has determined the added clinical value of a new pharmaceutical, Amgros will negotiate with the applicant

READ MORE
Health economics

New pharmaceuticals

If a new drug is to be considered as a standard treatment at Danish public hospitals, the Danish Medicines Council has to assess it first.

READ MORE

Sune Lindgaard

Head of Business Intelligence and Health Economy

I’m responsible for operation and development of business intelligence and health economics. I make sure that our department can proudly claim to be the partner who gets things done.